Old Web
English
Sign In
Acemap
>
authorDetail
>
Kattie Khadar
Kattie Khadar
National Institutes of Health
Medicine
Cancer
Phases of clinical research
Pathology
Cabozantinib
4
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase II study of cabozantinib (XL184) in patients with advanced/metastatic urothelial carcinoma.
2017
Journal of Clinical Oncology
Andrea B. Apolo
Howard L. Parnes
Ravi A. Madan
James L. Gulley
John J. Wright
Kattie Khadar
Jane B. Trepel
Jeffrey Schlom
Philip M. Arlen
Maria J. Merino
Seth M. Steinberg
Peter L. Choyke
Maria Liza Lindenberg
Karen Kurdziel
Les R. Folio
William D. Figg
Piyush K. Agarwal
Donald P. Bottaro
William L. Dahut
Show All
Source
Cite
Save
Citations (7)
A phase II study of cabazitaxel in patients with urothelial carcinoma who have disease progression following platinum-based chemotherapy.
2014
Journal of Clinical Oncology
Jean H. Hoffman-Censits
David J. Vaughn
Jianqing Lin
Stephen M. Keefe
Naomi B. Haas
William Kevin Kelly
Terry Hyslop
Monica McGuire
Janelle Robinson
Kattie Khadar
Swati Nanda
Brooke Kennedy
Andrea B. Apolo
Show All
Source
Cite
Save
Citations (7)
Assessment of bone metastases in patients (pts) with urothelial carcinoma using 18F-sodium fluoride PET/CT (18F-NaF) versus 18F-fluorodeoxyglucose PET/CT (18F-FDG).
2014
Journal of Clinical Oncology
Benjamin Adam Weinberg
Maria Liza Lindenberg
Karen Kurdziel
Seth M. Steinberg
David J. Liewehr
Kattie Khadar
Yolanda McKinney
Peter L. Choyke
Andrea B. Apolo
Show All
Source
Cite
Save
Citations (0)
Preclinical and correlative studies of cabozantinib (XL184) in urothelial cancer (UC).
2013
Journal of Clinical Oncology
Andrea B. Apolo
Young Hee Lee
Fabiola Cecchi
Piyush K. Agarwal
Howard L. Parnes
Kattie Khadar
Amelia Summerell
James L. Gulley
Kathryn Compton
William D. Figg
William L. Dahut
Donald P. Bottaro
Show All
Source
Cite
Save
Citations (8)
1